GenoPalate, Inc.
PrivateLast Round
Seed Round
Mar 4, 2026
Total Funding Raised
$14.09M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
GenoPalate, Inc. is a nutritional genomics company that provides personalized nutrition and supplement recommendations based on DNA analysis, blood biomarkers, and lifestyle data.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoPalate, Inc. Comparables
Compare GenoPalate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Silverberry Genomix | 84% | |
| Genomelink | 82% | |
| Rootine | 82% |
GenoPalate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 4, 2026 | ||||
| Series A Extension | Oct 25, 2022 | ||||
| Series A | Dec 29, 2020 | ||||
| Seed | Dec 3, 2018 | ||||
| Seed | Mar 29, 2018 | ||||
Accelerator | May 15, 2017 |
GenoPalate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Seed, Accelerator, Series B |
| BrightStar Wisconsin Foundation | Seed, Series B |
| gBETA | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 44% MoM.
- Jul 13, 2026
Open roles increased to 8, 62% of headcount.
Recent news
Latest coverage and updates
- hiresJul 14, 2026
GenoPalate hired Chris Connell as Vice President of Marketing & Operations on Jul 14th '26.
- hiresJun 23, 2026
GenoPalate Inc hired Hector Guillen as Chief Scientific Officer on Jun 23rd '26.
GenoPalate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenoPalate, Inc.'s valuation, stock price, and market status.
Is GenoPalate, Inc. a public or private company?
GenoPalate, Inc. is a private company.
What is the current stock price of GenoPalate, Inc.?
GenoPalate, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is GenoPalate, Inc. worth (valuation)?
Valuation information for GenoPalate, Inc. is not publicly available.
Can I buy GenoPalate, Inc. stock?
GenoPalate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenoPalate, Inc.'s last funding round?
GenoPalate, Inc.'s most recent funding round was Seed Round on March 4, 2026.
Who are the main investors in GenoPalate, Inc.?
Key investors in GenoPalate, Inc. include gener8tor.
Will GenoPalate, Inc. IPO soon?
No public IPO plans have been announced for GenoPalate, Inc..
How can I track GenoPalate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenoPalate, Inc.'s secondary market activity and sign up for updates.